Karo Pharma Smart choices for everyday healthcare About Products Karo Everyday Investors News & Press English Smart choices for everyday healthcare Most of us define our health as above average. Yet, 97% live with everyday health issues such as e.g. stress, sleep issues and digestive problems*. Imagine how great life would be if we didn’t have to live with such issues. So let’s decide not to. Karo Pharma delivers smart choices that give people control over their everyday healthcare. *IPSOS “Self Care: Be Your Best” Report, 2019 “The itching has been going for so long, I was starting to accept that this was just my skin.” – Male, Norway See all dermatology products Probiotics: The natural way to boost your wellbeing See all wellness products “I noticed my hemorrhoids as an early teen, but didn’t do anything about it for years.” – Male, UK See all intimate care products “The cortisone cream was a game changer for me. I felt the difference immediately.” – Male, Norway See all dermatology products 1 out of 5 adults live with toenail fungus – Global Nail Fungus Organization 2019 See all foot care products “We’ve made it our purpose to develop reliable ways for people to treat their everyday ailments, to help them live healthier lives. We call it smart choices for everyday healthcare.” Christoffer Lorenzen, CEO, Karo Pharma Press releases 22 November, 2021 Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m Karo Pharma Aktiebolag (publ) (the ”Company” or ”Karo”) has today entered into an agreement to acquire all of the shares… 7 September, 2021 Anna Hale appointed CMO at Karo Pharma Karo Pharma Aktiebolag (publ) (“Karo”) has appointed Anna Hale as the Chief Marketing Officer (CMO) of Karo. The appointment reflects Karo’s growth ambitions, fueled by a… 24 August, 2021 Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO Karo Pharma Aktiebolag (“Karo”) has appointed Matt Roberts as the new Chief Commercial Officer (CCO) of Karo, replacing Magnus Nylén… See all press releases Reports 28 October, 2021 Karo Pharma Quarterly report Q3 2021 July – September Revenues amounted to MSEK 738.5 (679.1), corresponding to an increase of +9% for the period. The organic… 22 July, 2021 Interim report Q2 2021 April – June Revenues amounted to MSEK 747.9 (688.9), corresponding to an increase of +9% for the period. The organic… 21 April, 2021 Interim report Q1 2021 January – March Revenues amounted to MSEK 713.0 (793.6), corresponding to a decrease of -10% for the period. The organic… See all reports We support Operation Smile Every three minutes, a child with cleft lip or palate is born. These children often live a tough life, having to endure harassment and isolation. Operation Smile perform about 15,000 surgeries a year – improving the lives of just as many children all over the world. For us this is a smart choice for everyday healthcare and why Karo Pharma has supported Operation Smile since 2018. You can read more about the medical missions in Malawi, Mozambique and Ghana, which our backing made possible, in our Annual Report. Learn more Products Financial reports Financial Press releases Contact Karo Pharma Follow us on LinkedIn Copyright© Karo Pharma AB 2021 Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy Approve